Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jintong Du

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
BMC Cancer|July 23, 2015
Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancerJintong Du, Bei Li, Yingli Fang, et al.
Journal of Chemical Information and Modeling|September 1, 2023
Deciphering the Allosteric Activation Mechanism of SIRT6 Using Molecular Dynamics SimulationsZhiyuan Zhao, Jintong Du, Yu Du, et al.
Journal of Medicinal Chemistry|February 14, 2022
Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor ImmunityChen Chen, Xue Li, Huajun Zhao, et al.
Oncology Letters|November 9, 2017
Distribution of uridine diphosphate glucuronosyltransferase 1A polymorphisms and their role in irinotecan-induced toxicity in patients with cancerYang Wang, Cuihua Yi, Yawei Wang, et al.
Medcomm|November 21, 2025
Preclinical Characterization of SDFZ-8, a Highly Potent HDAC1 Inhibitor, for Cancer ImmunotherapyYi Zhou, Jintong Du, Xue Li, et al.
Journal of Medicinal Chemistry|April 28, 2026
Discovery of Benzofuran-2-Carboxylic Acid Derivatives as Potent PTPRO Inhibitors with Oral Efficacy for Treatment of Inflammatory Bowel DiseaseXiao Liang, Xue Li, Junxin Xue, et al.
European Journal of Medicinal Chemistry|July 3, 2023
Discovery of benzofuran-2-carboxylic acid derivatives as lymphoid tyrosine phosphatase (LYP) inhibitors for cancer immunotherapyXiao Liang, Huajun Zhao, Jintong Du, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 16, 2025
A novel ionizable lipid with comprehensive improvements in transfection potency, immune profile and safety of lipid nanoparticleKun Guo, Lingling Bu, Jintong Du, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
BMC Cancer|July 23, 2015
Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancerJintong Du, Bei Li, Yingli Fang, et al.
Journal of Chemical Information and Modeling|September 1, 2023
Deciphering the Allosteric Activation Mechanism of SIRT6 Using Molecular Dynamics SimulationsZhiyuan Zhao, Jintong Du, Yu Du, et al.
Journal of Medicinal Chemistry|February 14, 2022
Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor ImmunityChen Chen, Xue Li, Huajun Zhao, et al.
Oncology Letters|November 9, 2017
Distribution of uridine diphosphate glucuronosyltransferase 1A polymorphisms and their role in irinotecan-induced toxicity in patients with cancerYang Wang, Cuihua Yi, Yawei Wang, et al.
Medcomm|November 21, 2025
Preclinical Characterization of SDFZ-8, a Highly Potent HDAC1 Inhibitor, for Cancer ImmunotherapyYi Zhou, Jintong Du, Xue Li, et al.
Journal of Medicinal Chemistry|April 28, 2026
Discovery of Benzofuran-2-Carboxylic Acid Derivatives as Potent PTPRO Inhibitors with Oral Efficacy for Treatment of Inflammatory Bowel DiseaseXiao Liang, Xue Li, Junxin Xue, et al.
European Journal of Medicinal Chemistry|July 3, 2023
Discovery of benzofuran-2-carboxylic acid derivatives as lymphoid tyrosine phosphatase (LYP) inhibitors for cancer immunotherapyXiao Liang, Huajun Zhao, Jintong Du, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 16, 2025
A novel ionizable lipid with comprehensive improvements in transfection potency, immune profile and safety of lipid nanoparticleKun Guo, Lingling Bu, Jintong Du, et al.
Pageof 2